Jouve, R <br/><br/>
Epoprostenol (PGI2) prevents postischemic ventricular fibrillation and improves outcome in a canine model of sudden death.  [electronic resource] 

 -  Journal de pharmacologie   
 - 139-57 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0021-793X 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Death, Sudden<br/>Disease Models, Animal<br/>Dogs<br/>Electrocardiography<br/>Epoprostenol--pharmacology<br/>Female<br/>Hemodynamics--drug effects<br/>Male<br/>Platelet Aggregation--drug effects<br/>Time Factors<br/>Ventricular Fibrillation--prevention & control